Thank you, Michael. On Page 4, we highlight the Company’s key metrics for 2017. Net income was $5.2 million, reflecting a $15.2 million net benefit from the new Tax Act. This benefit is due to the required remeasurement of our next deferred tax liability at the new lower corporate rate of 21%, effective January 1, 2018. We tend to have sizable deferred tax liabilities, related to the recognition of taxable income, and those are insurance and mortgage businesses. For the year, we had a pretax loss for non-controlling interest of $9.5 million, of which $3.3 million is from continuing operations and $6.2 million is from discontinued operations. Adjusted EBITDA ended the year at $38 million on a combined basis. Pretax income from continuing and discontinued operations declined a combined $52.8 million over 2016, and adjusted EBITDA was down $40.9 million. However, normalized EBITDA, which excludes stock-based compensation, realized and unrealized gains and losses and adjust for third-party non-controlling interest was slightly improved. Normalized EBITDA is a measure management considers when evaluating the ongoing earning capacity of our operations and our long-term return on invested capital. Our insurance company’s normalized EBITDA was up over 8%, supported by growth in both credit and warranty products. Corporate cost improved by $5.7 million as external audit fees and consulting expenses were substantially reduced. Interest expense was also reduced as we repaid a portion of our holding company indebtedness late in the year. Offsetting the growth in insurance and reduction in corporate expenses, where declines in distributions of $8.8 million, related to our CLO subordinated notes sale and lower management fees as our AUM declined. Our senior living business is now reported as discontinued operations. The $6.2 million pretax loss attributable to those operations is expected to be replaced in 2018 by approximately $12.1 million in dividend income from our ownership of Invesque stock. Several nonrecurring items also impacted our 2017 results. As we discussed in Q2, Reliance’s strong performance over the 12-month period ended June 30, 2017, drove an increase in expense of $3 million, related to the earn out paid in Tiptree shares to the former shareholders. At our insurance subsidiary, we recognized a $1.2 million charge related to debt extinguishment, as a result of the repayment of our senior credit facility. Lastly, as Michael has already mentioned, the single largest contributor to our comparable year-over-year performance was a negative unrealized mark-to-market on equities in 2017 versus unrealized gains in 2016. On this point, I’d like to mention that there has been a change in accounting for the insurance industry, beginning January 1. All insurance companies will begin to report their unrealized gains and losses on equity positions through income in the period recognized. Previously, the insurance industry accounted for unrealized gains and losses on equities in AOCI, impacting book value but not earnings. We have always reported our unrealized gain and loss positions on our equity securities through income, which has historically been a difference relative to our peers. Going forward, the change in accounting will make for easier comparison. On the next page, we outlined our capital allocation snapshot for the year. Book value per share as exchanged declined 1.7% year-over-year. The decline was a result of the unrealized losses, the issuance of shares related to the exercise of the founder’s option and the Reliance earn out along with dividends paid. This was partially offset by a $0.35 per share tax benefit, resulting from the enactment of the tax act in late December. In addition, operations contributed $0.27 of EPS, and we recognized a $0.07 benefit from repurchasing shares below book. Though embedded in our GAAP equity as of year-end 2017 is the accumulated depreciation on our real estate asset, along with purchase accounting amortization on our insurance company. These combined represent a reduction in value of $1.77 as of December 2017, as compared to $1.37 at this point in 2016. We expect approximately half of this impact will be reversed in GAAP book value per share in the first quarter of 2018 when we report the gain on our Care sale. On the bottom left, you can see how our total capital is currently allocated across our businesses, with approximately 70% concentrated in the insurance sector. Normalized EBITDA, return on total capital was 9.6% over the last year, with strong performances from our insurance business, partially offset by declines in Tiptree Capital, primarily related to lower distributions on our subordinated note. Moving to Page 7. We provide further details regarding our specialty insurance performance. First, we will focus on insurance operations, and then on the next page, performance from the insurance investment portfolio. We continue to see positive top line growth from all of our product lines. For 2017, gross written premiums grew by 8.3% over the prior year. The impact of increases in gross written premium may not be seen immediately in our financial results, as a significant portion of the new premium will be earned over longer periods of times than our older products. A 19.9% growth in unearned premium reserve and deferred revenue on our balance sheet will give you a perspective of the future revenues that we expect to earn over time. Pretax income and adjusted EBITDA from insurance operations were down year-over-year. Adjusted underwriting margin, a measure of our product’s profitability was up $4.4 million and trending positively, driven by better performance in our credit protection and warranty program. This was offset by $4 million in stock-based compensation, along with an increase of $5.6 million in other expenses, primarily related to premium tax increases, as written premiums continue to grow. The adjusted combined ratio for the year was 93.2%, up 3.7 percentage points from the prior year. This metric is within our parameters of expected underwriting performance from year-to-year. Looking forward, we plan to continue to focus on our warranty products and program businesses to drive premium growth. Turning to the insurance investment portfolio on Page 8. You can see the growth in net investments over the past year. This growth was driven by a combination of several factors, including the assumption of reinsurance contracts and growth in written premiums. Our investment portfolio earnings in 2017 were down primarily due to unrealized equity losses. Excluding those losses, net portfolio income for the year was $15.5 million, up $1 million, driven by increases in interest income, primarily related to LIBOR-earning assets, an improvement in realized gains from sales of nonperforming mortgage loans. As we go forward, while volatility related to our mark-to-market investments are expected to continue from quarter-to-quarter, our objectives remain the same: To balance our portfolio between cash and liquid short-term investment; to cover claims; and select alternative investment with a focus on enhanced risk-adjusted total returns over the long term. On Page 10, we present the result of Tiptree Capital, where we allocate our capital across a broad spectrum of investment. Today, Tiptree Capital consists of asset management operations, mortgage operations and other investment. Our senior living results now discontinued operations are included here for 2017. Beginning in 2018, the dividend income from our ownership of Invesque will be reported in other investment as part of Tiptree Capital. Asset management and credit investment pretax income for the year was $14.2 million, down $11 million over 2016. Our financial results for 2017 were positively impacted by the fair value adjustment of $3.9 million on our investment in the CLO sub-note. The fair value gain similar to the first half were driven by the strength in the loan market and the refinancing of one of our CLO. More than offsetting those increases, were the declines in distribution and lower base management fees mentioned earlier. Mortgage operations were impacted by lower volumes as mortgage interest rates rose during 2017 and were only partially offset by improved margins. Now we will turn the call back to Michael to conclude our prepared remarks.